Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome
Mathias Schneeweiss‐Gleixner(Medical University of Vienna), Albert Friedrich Stättermayer(Medical University of Vienna), Christoph Krall(Medical University of Vienna), Katharina Krenn(Medical University of Vienna), Lukas Hartl(Medical University of Vienna), Felix Kraft(Medical University of Vienna), Lukas Adam(Medical University of Vienna), Nina Buchtele(Medical University of Vienna), Thomas Staudinger(Northwestern University), Emina Halilbasic(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Michael Trauner(Medical University of Vienna), Patrick Haselwanter(Medical University of Vienna), Mathias Petter(Medical University of Vienna), Christian Zauner(Medical University of Vienna)
Cited by 3
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
|Intensive Care Medicine|2013|603
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561